Aug 19 |
BioMarin to Host 2024 Investor Day on September 4th in New York
|
Aug 13 |
Here's Why You Should Invest in BioMarin (BMRN) Stock Now
|
Aug 13 |
Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term
|
Aug 13 |
3 US Stocks That May Be Undervalued According To Estimates
|
Aug 12 |
BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why
|
Aug 12 |
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
Aug 10 |
Piper lists eight defensive biotechs to face market volatility
|
Aug 9 |
BioMarin Pharmaceutical Inc (BMRN): Are Hedge Funds Bullish on This Elliott Management-Approved Stock Now?
|
Aug 7 |
BioMarin Pharmaceutical Second Quarter 2024 Earnings: Beats Expectations
|
Aug 6 |
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
|